The results were significant: Average weight loss of 20.7% of starting body weight over a span of 72 weeks among participants who stayed on treatment, compared to 17.5% with the standard 2.4 mg dose
Step 7: Initiate Therapy with Structured Monitoring Begin GLP-1 therapy with a clear, structured plan for monitoring progress and adjusting treatment as needed
PCOS Sisters Metabolic Weight Loss Program Symptoms PCOS Treatment Details For many women, losing weight is already a challengebut with PCOS, it can feel nearly impossible
Early data suggests Retatrutide may preserve lean mass slightly better than Tirzepatide, though direct head-to-head comparisons specifically examining body composition in training populations are not available
Saeedi P, Salpea P, Karuranga S, Petersohn I, Malanda B, Gregg EW, Unwin N, Wild SH, Williams R (2020) Mortality attributable to diabetes in 2079 years old adults, 2019 estimates: results from the International Diabetes Federation Diabetes Atlas, 9(th) edition
At Aegis Peptides, all Retatrutide products are supplied strictly for laboratory and scientific research purposes only